Heiko Jessen

10.9k total citations · 2 hit papers
71 papers, 4.8k citations indexed

About

Heiko Jessen is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Heiko Jessen has authored 71 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 35 papers in Virology and 28 papers in Epidemiology. Recurrent topics in Heiko Jessen's work include HIV Research and Treatment (35 papers), HIV/AIDS Research and Interventions (27 papers) and HIV/AIDS drug development and treatment (24 papers). Heiko Jessen is often cited by papers focused on HIV Research and Treatment (35 papers), HIV/AIDS Research and Interventions (27 papers) and HIV/AIDS drug development and treatment (24 papers). Heiko Jessen collaborates with scholars based in Germany, United States and Canada. Heiko Jessen's co-authors include Anna R. Giuliano, Joel M. Palefsky, Edson Duarte Moreira, Scott Vuocolo, Richard M. Haupt, J. Brooke Marshall, Dalya Güriş, Stephen E. Goldstone, Carlos Aranda and Richard J. Hillman and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Heiko Jessen

70 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

2011 821 citations Anna R. Giuliano, Joel M. Palefsky et al. New England Journal of Medicine profile →
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 650 citations Joel M. Palefsky, Anna R. Giuliano et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Heiko Jessen

Since Specialization

Citations

This map shows the geographic impact of Heiko Jessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiko Jessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiko Jessen more than expected).

Fields of papers citing papers by Heiko Jessen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiko Jessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiko Jessen. The network helps show where Heiko Jessen may publish in the future.

Co-authorship network of co-authors of Heiko Jessen

This figure shows the co-authorship network connecting the top 25 collaborators of Heiko Jessen. A scholar is included among the top collaborators of Heiko Jessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiko Jessen. Heiko Jessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort 2021 ·AIDS Research and Therapy ·Trevor A. Crowell, Haoyu Qian, Carsten Tiemann, Clara Lehmann, Christoph Boesecke, Albrecht Stoehr, (unknown), Stefan Eßer, Markus Bickel, Christoph D. Spinner, (unknown), (unknown), Norbert H. Brockmeyer, Heiko Jessen, Merlin L. Robb, Nelson L. Michael, Klaus Jansen, Hendrik Streeck, (unknown)	3
2	Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany 2021 ·BMC Public Health ·Uwe Koppe, Ulrich Marcus, Stefan Albrecht, Klaus Jansen, Heiko Jessen, Barbara Gunsenheimer‐Bartmeyer, Viviane Bremer	27
3	Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventions 2020 ·International Journal of Infectious Diseases ·Ruth Zimmermann, Mirko Faber, Sandra Dudareva, Patrick Ingiliz, Heiko Jessen, Judith Koch, Ulrich Marcus, Kai Michaelis, Thorsten Rieck, Claudia Ruscher, (unknown), (unknown), Dagmar Sissolak, (unknown), Jürgen J. Wenzel, Dirk Werber, Daniel Sagebiel	16
4	A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review 2019 ·PLoS ONE ·Joseph Cox, Cassidy A. Gutner, Nadine Kronfli, (unknown), (unknown), (unknown), (unknown), Tristan Barber, Davide Croce, David J. Hardy, Heiko Jessen, Christine Katlama, Josep Mallolas, Giuliano Rizzardini, (unknown), Michael Wohlfeiler, (unknown)	17
5	Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin – A multicentre, cross-sectional survey 2018 ·PLoS ONE ·Ricardo Niklas Werner, Matthew Gaskins, (unknown), Heiko Jessen, (unknown), (unknown), W. Oßwald, Dirk Sander, (unknown), (unknown), Thomas Wünsche, Corinna Dressler, (unknown), Alexander Nast	20
6	Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection 2017 ·Journal of Interferon & Cytokine Research ·Yanpeng Li, Binlian Sun, Stefan Eßer, Heiko Jessen, Hendrik Streeck, Marek Widera, Rongge Yang, Ulf Dittmer, Kathrin Sutter	17
7	Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic 2016 ·PLoS ONE ·(unknown), Heiko Jessen, Ute A. Kopp, Arne Jessen, Katrin Hahn	20
8	Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors 2015 ·Journal of Virology ·Mako Toyoda, Yoko Ogata, (unknown), Yosuke Maeda, Xiaomei T. Kuang, Toshiyuki Miura, Heiko Jessen, Bruce D. Walker, Mark A. Brockman, Zabrina L. Brumme, Takamasa Ueno	21
9	High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany 2015 ·PLoS ONE ·Klaus Jansen, Michael Thamm, C.–Thomas Bock, Ramona Scheufele, Claudia Kücherer, (unknown), Hans‐Jochen Hagedorn, Heiko Jessen, S Dupke, Osamah Hamouda, Barbara Gunsenheimer‐Bartmeyer, Karolin Meixenberger, (unknown)	62
10	Temporal effect of HLA-B57 on viral control during primary HIV-1 infection 2013 ·Retrovirology* ·Sagar A. Vaidya, Hendrik Streeck, Noor Beckwith, Musie Ghebremichael, Florencia Pereyra, Douglas S. Kwon, Marylyn M. Addo, Jenna Rychert, Jean‐Pierre Routy, Heiko Jessen, Anthony D. Kelleher, Frederick Hecht, Rafick‐Pierre Sékaly, Mary Carrington, Bruce D. Walker, Todd M. Allen, Eric Rosenberg, Marcus Altfeld	10
11	Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males breakdown → 2011 ·New England Journal of Medicine ·Anna R. Giuliano, Joel M. Palefsky, Stephen E. Goldstone, Edson Duarte Moreira, Mary E. Penny, Carlos Aranda, Eftyhia Vardas, Harald Moi, Heiko Jessen, Richard J. Hillman, Yen-Hwa Chang, Daron Ferris, Danielle Rouleau, Janine T. Bryan, J. Brooke Marshall, Scott Vuocolo, Eliav Barr, David Radley, Richard M. Haupt, Dalya Güriş	821
12	IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells 2009 ·Blood ·Mark A. Brockman, Douglas S. Kwon, (unknown), David F. Pavlik, Pamela C. Rosato, Jennifer Sela, Filippos Porichis, Sylvie Le Gall, Michael T. Waring, (unknown), Heiko Jessen, Florencia Pereyra, Daniel G. Kavanagh, Bruce D. Walker, Daniel E. Kaufmann	225
13	Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort 2009 ·European journal of medical research ·(unknown), (unknown), Eva Wolf, (unknown), Heiko Jessen, Knud Schewe, Michael Rausch, (unknown), Andreas Goetzenich, Heribert Knechten, H. Jaeger	18
14	Transmission and Long-Term Stability of Compensated CD8 Escape Mutations 2008 ·Journal of Virology ·Arne Schneidewind, Zabrina L. Brumme, Chanson J. Brumme, Karen A. Power, Laura L. Reyor, Kristin O’Sullivan, Adrianne D. Gladden, (unknown), Thomas Kuntzen, Yaoyu E. Wang, Cesar Oniangue-Ndza, Heiko Jessen, Martin Markowitz, Eric Rosenberg, Rafick‐Pierre Sékaly, Anthony D. Kelleher, Bruce D. Walker, Todd M. Allen	49
15	CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual 2008 ·PLoS ONE ·Djin‐Ye Oh, Heiko Jessen, Claudia Kücherer, Konrad Neumann, (unknown), Gabriele Poggensee, Barbara Gunsenheimer‐Bartmeyer, Arne Jessen, Axel Prüß, Ralf R. Schumann, Osamah Hamouda	32
16	Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome 2008 ·AIDS ·Hendrik Streeck, Heiko Jessen, (unknown), Bin Li, Arne Jessen, S Dupke, Axel Baumgarten, Ingrid Stahmer, Jan van Lunzen, Marcus Altfeld, Bruce D. Walker, Todd M. Allen	1
17	Impact of transmission of drug‐resistant HIV on the course of infection and the treatment success. Data from the German HIV‐1 Seroconverter Study 2007 ·HIV Medicine ·G Poggensee, Claudia Kücherer, (unknown), (unknown), B Bieniek, S Dupke, Heiko Jessen, Osamah Hamouda, (unknown)	43
18	Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon®) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy 2007 ·Virus Genes ·Vladimir A. Morozov, А. В. Морозов, (unknown), Heiko Jessen, Claudia Kücherer	14
19	Immune Restoration by Combination of a Cytostatic Drug (Hydroxyurea) and Anti-HIV Drugs (Didanosine and Indinavir) 1999 ·AIDS Research and Human Retroviruses ·Franco Lori, Heiko Jessen, Judy Lieberman, Mario Clerici, Carmine Tinelli, Julianna Lisziewicz	28
20	Treatment of Human Immunodeficiency Virus Infection with Hydroxyurea, Didanosine, and a Protease Inhibitor before Seroconversion Is Associated with Normalized Immune Parameters and Limited Viral Reservoir 1999 ·The Journal of Infectious Diseases ·Franco Lori, Heiko Jessen, Judy Lieberman, Diana Finzi, Eric Rosenberg, Carmine Tinelli, Bruce D. Walker, Robert F. Siliciano, Julianna Lisziewicz	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact